Approval · Notice of Compliance 9795 · 2008
ACTONEL: Notice of Compliance 9795
Issued September 24, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9795
- Date
- September 24, 2008
- Company
- Procter & Gamble Pharmaceuticals Canada, IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 150 mg tablet and new dosing regimen
- Therapeutic class
- Bone metabolism regulator
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTONEL | 02316838 | Marketed |
Medicinal ingredients
- RISEDRONATE SODIUM 150 MG per TAB